Literature DB >> 27328622

Association of eNOS and ACE gene polymorphisms and plasma nitric oxide with risk of non-small cell lung cancer in South India.

Vidyullatha Peddireddy1,2, Siva Prasad Badabagni1, Sandhya Devi Gundimeda3, Hema Prasad Mundluru1.   

Abstract

INTRODUCTION: The role of ACE and eNOS gene polymorphisms and their association with various cancers were reported. However, their role in the lung cancer is unclear.
OBJECTIVES: In this study, we analyzed eNOS and ACE gene polymorphisms and the risk of non-small cell lung cancer (NSCLC) in South Indian population.
RESULTS: For the eNOS gene, the homozygous "AA" genotypic frequency was significantly associated with NSCLC with an overall risk of 3.6-fold (P = 0.006, odds ratio = 3.58, 95% confidence interval = 1.66, 7.723). The heterozygous "I/D" genotypic frequency of ACE gene was significantly higher in NSCLC patients when compared to the controls with a 2.29-fold risk for NSCLC. Multiple regression analyses indicated that gender, smoking status, and polymorphisms in eNOS and ACE genes as the strongest predicting factors for an increased susceptibility to NSCLC.
CONCLUSIONS: We report for the first time that polymorphisms in the eNOS "A/A" (homozygous mutant) and ACE "I/D" genotypes might contribute to the increased risk of NSCLC in the South Indian population.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  angiotensin converting enzyme; gene polymorphism; nitric oxide; nitric oxide synthase; non-small cell lung cancer

Mesh:

Substances:

Year:  2016        PMID: 27328622     DOI: 10.1111/crj.12517

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

Review 1.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

3.  Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer.

Authors:  Zafer Bayraktutan; Ahmet Kiziltunc; Ebubekir Bakan; Hamit Hakan Alp
Journal:  Eurasian J Med       Date:  2020-06-05

4.  Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan.

Authors:  Chun-Yao Huang; Ming-Ju Hsieh; Wen-Jun Wu; Whei-Ling Chiang; Tu-Chen Liu; Shun-Fa Yang; Thomas Chang-Yao Tsao
Journal:  J Cancer       Date:  2018-06-15       Impact factor: 4.207

5.  Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis.

Authors:  Mohammed Batais; Turky Almigbal; Khalid Alotaibi; Abdulaziz Alodhayani; Abdullah Alkhushail; Abdulrahman Altheaby; Mashhor Alhantoushi; Saad Alsaad; Sultan Al Dalbhi; Yasser Alghamdi
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

6.  A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.

Authors:  Debmalya Sengupta; Souradeep Banerjee; Pramiti Mukhopadhyay; Ritabrata Mitra; Tamohan Chaudhuri; Abhijit Sarkar; Gautam Bhattacharjee; Somsubhra Nath; Susanta Roychoudhury; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

7.  Effect of microRNA-181b on the biological characteristics and clinical drug resistance of small-cell lung cancer by targeting angiotensin converting enzyme 2.

Authors:  Guang Yang; Wenhao Wang; Shaohui Han; Siwei Xu; Huining Liu
Journal:  Thorac Cancer       Date:  2022-01-17       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.